Today: 9 June 2026
UOB stock slips in Singapore after JPMorgan downgrade — here’s what investors watch next
26 January 2026
1 min read

UOB stock slips in Singapore after JPMorgan downgrade — here’s what investors watch next

Singapore, Jan 26, 2026, 14:51 SGT — Regular session

  • UOB shares fell 2.7% to S$38.45 in afternoon trading, underperforming other local banks
  • JPMorgan downgraded UOB to “underweight” but left its target price steady at S$34
  • Attention shifts to UOB’s full-year results for Feb 24

United Overseas Bank Ltd (UOB) shares dropped on Monday, falling 2.66% to S$38.45 by 2:48 p.m. local time, after touching a high of S$39.20 earlier. The Straits Times Index in Singapore dipped 0.69%. DBS shares slipped 0.8%, while OCBC dropped 1.22%.

The pullback follows UOB’s record close on Friday, but selling pressure emerged after JPMorgan downgraded the stock, The Business Times reported. JPMorgan shifted its rating from “neutral” to “underweight,” signaling expectations that the stock will underperform its peers, while maintaining a target price of S$34, the report added. The Business Times

JPMorgan told The Edge Singapore it doesn’t expect asset quality concerns to be fully resolved by 4Q2025. It also ranked UOB behind DBS and OCBC in a new “pecking order.” The bank pointed to risks from commercial real estate, rising credit costs in Thailand, and tighter liquidity in Indonesia as reasons UOB’s shares could lose steam after a strong rally. The Edge Singapore

At the moment, this appears more like profit-taking disguised as something else. UOB had been a top performer among Singapore’s banks, and Monday’s dip is cutting back on those gains—though it’s far from wiping them out.

Traders are keeping an eye on whether the selling spreads across the sector. Singapore’s major lenders have been trading more in unison recently, and because UOB carries significant weight, any sharp move there can quickly impact the benchmark.

The downside scenario is clear. If loan demand weakens, funding costs hit harder than anticipated, or provisions climb once more, the stock could slide further—even without fresh headlines.

The next major trigger is coming up fast: UOB is set to report its full-year 2025 results on Feb 24, ahead of market open, according to a filing with the Singapore Exchange.

Investors will focus on any changes in comments about asset quality, updates on credit cost forecasts, and management’s stance on capital and shareholder returns.

For now, the tape speaks for itself — and if broker downgrades extend past JPMorgan, it might signal more than a brief breather after a record run, potentially marking the start of a broader reset ahead of earnings.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
MinebeaMitsumi stock price slides in Tokyo as yen firms; Feb. 5 earnings loom
Previous Story

MinebeaMitsumi stock price slides in Tokyo as yen firms; Feb. 5 earnings loom

Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks
Next Story

Netflix to Paramount: Your Warner Bros bid “doesn’t pass the sniff test” as takeover clock ticks

Go toTop